Entry Detail



General Information

Database ID:exR0755327
RNA Name:ABRAXAS1
RNA Type:mRNA
Chromosome:chr4
Starnd:-
Coordinate:
Start Site(bp):83459517End Site(bp):83523348
External Links:ENSG00000163322



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE106804
Description:Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:13
Number of Control:6
Number of Samples:19





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ARF6
chr14
49893082
49897054
+
ARHGAP11B
chr15
30624494
30649529
+
CEBPZ
chr2
37201612
37231596
-
CHD8
chr14
21385194
21456126
-
CSDE1
chr1
114716913
114758676
-
DYRK1A
chr21
37365573
37526358
+
DYRK3
chr1
206635536
206684419
+
ETF1
chr5
138506095
138543236
-
FADS2
chr11
61792980
61867354
+
HELQ
chr4
83407343
83455855
-
KDM3A
chr2
86440647
86492716
+
PLEKHA5
chr12
19129752
19376400
+
POU6F1
chr12
51186936
51217708
-
PRDM4
chr12
107732871
107761272
-
REXO4
chr9
133406059
133418096
-
STK17B
chr2
196133583
196176503
-
TOMM20
chr1
235109341
235128837
-
XRCC6
chr22
41621119
41664048
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:NA
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:29330365
Title:Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
Author:Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL.
Journal:Nat Commun. 2018 Jan 12;9(1):175.
Description:Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.